Investors Title Company ITIC Q4 2025 Earnings Strong EPS Performance Amid Quiet Period MRNA Q1 2026 Earnings Loss Narrower Than Expected But Stock Slips Amid Unreported Revenue EFSCP Q1 2026 Earnings EPS Misses Estimates Shares Edge Lower Nuvalent Inc NUVL Q1 2026 Earnings Slightly Wider Loss No Revenue Yet as PreClinical Pipeline Progresses PHGE Q4 2025 Earnings Deep EPS Miss Overshadowed by 103 Stock Surge RLMD Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Continues RD Investment